{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-269654","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.069624+00:00","generated_at":"2026-05-16T23:45:41.726718+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Organogenesis posts record Q3 revenue of $150.5M, raises FY2025 guidance","bullets":["Net product revenue $150.5M (+31% YoY); Advanced Wound Care $141.5M (+31%), Surgical & Sports Med $9.0M (+25%).","Net income $21.6M ($0.11 diluted EPS) vs $12.3M ($0.09) YoY; adjusted net income $23.2M.","Adjusted EBITDA $30.1M vs $13.4M YoY; operating income $20.7M vs $6.2M.","FY2025 revenue guidance raised to $500-525M (4-9% YoY); Adj. net income guided $21.5-38.4M.","Cash $64.4M, no debt; cash down from $136.2M due to operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-269654","json":"https://secwatch.observer/filing/0001193125-25-269654.json","markdown":"https://secwatch.observer/filing/0001193125-25-269654.md","text":"https://secwatch.observer/filing/0001193125-25-269654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000119312525269654/0001193125-25-269654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000119312525269654/orgo-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:45:41.726718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}